RxDoctor Payments Data

Anne Tann, MD

Radiation Oncology · Temple, TXNPI 1386901395

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $385 of the $474 with a category attached, or 81.2%. 7 manufacturers reported payments, led by GT Medical Technologies, Inc at 42.7% of the total. 2025 is the largest year on record at $199, 6.6 times the $30 reported in 2020. That places this record below the midpoint for radiation oncology clinicians in TX, where the typical reported total is $554.

$474in general payments, 2019–2025

Across 11 payments — averaging $43.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GT Medical Technologies, Inc$202
  • Brainlab, Inc.$146
  • Boston Scientific$53
  • Palette Life Sciences, Inc.$24
  • Tactile Systems Technology Inc$19
  • Bayer$16
  • plus $13 from 1 others
$86,901in research payments, 2019–2025

Across 48 payments — averaging $1810.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novocure GmbH$87K

What the payments were for

  • Travel & lodging$8919%
  • Food & beverage$38581%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$474 in reported general payments places this provider in the 40th percentile of 418 radiation oncology providers in Texas.

See all radiation oncology providers in Texas

Medicare billing

Part B allowed, 2024
$135,532
Medicare patients
254
Services billed
1,714

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Temple

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →